GAP-486 (ZP-123)

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Arrhythmia

Phase 2

Study Evaluating GAP-486 in Heart Rhythm

TerminatedNCT00137293

Wyeth is now a wholly owned subsidiary of PfizerArrhythmia

Start: 2005-11-30End: 2006-10-31Target: 30Updated: 2007-12-10

Study Evaluating GAP-486 on Heart Rhythm in Patients With Coronary Artery Disease

TerminatedNCT00137332

Wyeth is now a wholly owned subsidiary of PfizerArrhythmia

Start: 2005-11-30End: 2006-10-31Target: 90Updated: 2007-12-10